Summary
The interaction of Ro 15-1788 (5 mg kg−1 i.p.), a benzodiazepine antagonist, with GABA-ergic drugs muscimol (1.4 mg kg−1 i.p.), fenibut (100 mg kg−1 i.p.) and baclofen (5 mg kg−1 i.p.) was examined in behavioural and biochemical studies in rats. All the above-mentioned GABA-ergic drugs produced motor depression and with the exception of muscimol, where anti-aggressive effect was evident, fenibut and baclofen showed only slight antiagressive properties. Ro 15-1788 attenuated the motor depression produced by these compounds but potentiated their antiaggressive effect. Moreover, it was found that Ro 15-1788 itself possessed dose-related antiagressive properties. Fenibut increased, whereas muscimol and Ro 15-1788 decreased, the GABA content in the rat striatum. Ro 15-1788 and all the studied GABA-ergic compounds increased the level of the dopaminc metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) in the striatum. In spite of this no further increase of DOPAC was observed after concomitant use of Ro 15-1788 with GABA-ergic drugs. The action of investigated GABA-ergic drugs via GABA receptors linked to benzodiazepine receptors is suggested.
This is a preview of subscription content, log in via an institution to check access.
References
Allikmets LH, Rägo LK, Nurk AM (1982) The influence of the GABA-receptor blockade on the effects of fenibut and diazepam. Bull Exp Biol Med 5:64–65
De Feudis FV (1981) Muscimol binding and GABA receptors. Drug Dev Res 1:93–105
Earley CJ, Leonard BE (1978) Isolation and assay of noradrenaline, dopamine, 5-hydroxytryptamine and several metabolites from brain tissue using disposable Bio-Rad columns packed with Sephadex G-10. J Pharmacol Meth 1:67–79
Glowinski J, Iversen LL (1966) Regional studies of catecholamines in the rat brain. J Neurochem 13:655–669
Gundlach AL, Beart PM (1980) Effect of muscimol on dopamine metabolism of the rat hypothalamus. Experimentia 36:1312–1313
Hill DR, Bowery NG (1981) 3H-Baclofen and 3H-GABA bind to bicuculline-insensitive GABAB sites in rat brain. Nature 290:149–152
Hunkler W, Möhler H, Pieri L, Polc P, Bonetti EP, Cumin R, Schaffner R, Haefely W (1981) Selective antagonists of benzodiazepines. Nature 290:514–516
Iversen LL, Spokes E, Bird E (1978) GABA systems in human brain Huntington's disease and schizophrenia. In: Neurotransmitters, vol 2. Advances in pharmacology and therapeutics. Proc. 7th International Congress of Pharmacology, Paris, pp 3–10
Polc P, Laurent J-P, Scherschlicht R, Haefely W (1981) Electrophysiological studies on the specific benzodiazepine antagonist Ro 15-1788. Naunyn-Schmiedeberg's Arch Pharmacol 316:317–325
Roberts PJ, Gupta HK, Shargill NS (1978) The interaction of baclofen (β-[4-chlorophenyl] GABA) with GABA systems in rat brain: evidence for a releasing action. Brain Res 155:209–214
Rägo LK, Nurk AM, Korneyev AYa, Allikmets LH (1982) Fenibut binds to bicuculline insensitive GABA receptors in the rat brain. Bull Exp Biol Med 11:58–59
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Allikmets, L.H., Rägo, L.K. The action of benzodiazepine antagonist Ro 15-1788 on the effects of GABA-ergic drugs. Naunyn-Schmiedeberg's Arch. Pharmacol. 324, 235–237 (1983). https://doi.org/10.1007/BF00503902
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00503902